Successful treatment of severe arterial hypotension and anuria in a preterm infant with renal tubular dysgenesis- a case report.

Maternal health, neonatology and perinatology Pub Date : 2018-12-20 eCollection Date: 2018-01-01 DOI:10.1186/s40748-018-0095-z
Katharina Ruf, Johannes Wirbelauer, Antje Beissert, Eric Frieauff
{"title":"Successful treatment of severe arterial hypotension and anuria in a preterm infant with renal tubular dysgenesis- a case report.","authors":"Katharina Ruf,&nbsp;Johannes Wirbelauer,&nbsp;Antje Beissert,&nbsp;Eric Frieauff","doi":"10.1186/s40748-018-0095-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Oligohydramnios sequence can be caused by renal tubular dysgenesis (RTD), a rare condition resulting in pulmonary and renal morbidity. Besides typical features of Potter-sequence, the infants present with severe arterial hypotension and anuria as main symptoms. Establishing an adequate arterial blood pressure and sufficient renal perfusion is crucial for the survival of these infants.</p><p><strong>Case presentation: </strong>We describe a male preterm infant of 34 + 0 weeks of gestation. Prenatally oligohydramnios of unknown cause was detected. After uneventful delivery and good adaptation the infant developed respiratory distress due to a spontaneous right-sided pneumothorax and required thoracocentesis and placement of a chest tube; he showed no major respiratory concerns thereafter and needed only minimal ventilatory support. Echocardiography revealed no abnormalities, especially no pulmonary hypertension. However, he suffered from severe arterial hypotension and anuria refractory to catecholamine therapy (dobutamine, epinephrine and noradrenaline). After 36 h of life, vasopressin therapy was initiated resulting in an almost immediate stabilization of arterial blood pressure and subsequent onset of diuresis. Therapy with vasopressin was necessary for three weeks to maintain adequate arterial blood pressure levels and diuresis. Sepsis and adrenal insufficiency were ruled out as inflammation markers, microbiological tests and cortisol level were normal. At two weeks of age, our patient developed electrolyte disturbances which were successfully treated with fludrocortisone. He did not need renal replacement therapy. Genetic analyses revealed a novel compound hyterozygous mutation of RTD. Now 17 months of age, the patient is in clinically stable condition with treatment of fludrocortisone and sodium bicarbonate. He suffers from stage 2 chronic kidney disease; blood pressure, motor and cognitive development are normal.</p><p><strong>Conclusions: </strong>RTD is a rare cause of oligohydramnios sequence. Next to pulmonary hypoplasia, severe arterial hypotension is responsible for poor survival. We present the only second surviving infant with RTD, who did not require renal replacement therapy during the neonatal period. It can be speculated whether the use of vasopressin prevents renal replacement therapy as vasopressin increases urinary output by improving renal blood flow.</p>","PeriodicalId":74120,"journal":{"name":"Maternal health, neonatology and perinatology","volume":"4 ","pages":"27"},"PeriodicalIF":0.0000,"publicationDate":"2018-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40748-018-0095-z","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Maternal health, neonatology and perinatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40748-018-0095-z","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

Abstract

Background: Oligohydramnios sequence can be caused by renal tubular dysgenesis (RTD), a rare condition resulting in pulmonary and renal morbidity. Besides typical features of Potter-sequence, the infants present with severe arterial hypotension and anuria as main symptoms. Establishing an adequate arterial blood pressure and sufficient renal perfusion is crucial for the survival of these infants.

Case presentation: We describe a male preterm infant of 34 + 0 weeks of gestation. Prenatally oligohydramnios of unknown cause was detected. After uneventful delivery and good adaptation the infant developed respiratory distress due to a spontaneous right-sided pneumothorax and required thoracocentesis and placement of a chest tube; he showed no major respiratory concerns thereafter and needed only minimal ventilatory support. Echocardiography revealed no abnormalities, especially no pulmonary hypertension. However, he suffered from severe arterial hypotension and anuria refractory to catecholamine therapy (dobutamine, epinephrine and noradrenaline). After 36 h of life, vasopressin therapy was initiated resulting in an almost immediate stabilization of arterial blood pressure and subsequent onset of diuresis. Therapy with vasopressin was necessary for three weeks to maintain adequate arterial blood pressure levels and diuresis. Sepsis and adrenal insufficiency were ruled out as inflammation markers, microbiological tests and cortisol level were normal. At two weeks of age, our patient developed electrolyte disturbances which were successfully treated with fludrocortisone. He did not need renal replacement therapy. Genetic analyses revealed a novel compound hyterozygous mutation of RTD. Now 17 months of age, the patient is in clinically stable condition with treatment of fludrocortisone and sodium bicarbonate. He suffers from stage 2 chronic kidney disease; blood pressure, motor and cognitive development are normal.

Conclusions: RTD is a rare cause of oligohydramnios sequence. Next to pulmonary hypoplasia, severe arterial hypotension is responsible for poor survival. We present the only second surviving infant with RTD, who did not require renal replacement therapy during the neonatal period. It can be speculated whether the use of vasopressin prevents renal replacement therapy as vasopressin increases urinary output by improving renal blood flow.

Abstract Image

Abstract Image

Abstract Image

成功治疗严重动脉低血压和无尿的早产儿肾小管发育不良- 1例报告。
背景:羊水过少可由肾小管发育不良(RTD)引起,这是一种罕见的疾病,可导致肺部和肾脏疾病。除了波特序列的典型特征外,婴儿以严重的动脉低血压和无尿为主要症状。建立适当的动脉血压和充足的肾脏灌注对这些婴儿的生存至关重要。病例介绍:我们描述了一个34 + 0孕周的男性早产儿。产前发现不明原因羊水过少。在顺利分娩和良好的适应后,由于自发性右侧气胸,婴儿出现呼吸窘迫,需要胸腔穿刺术和放置胸管;此后他没有出现严重的呼吸问题,只需要最低限度的呼吸支持。超声心动图未见异常,尤其未见肺动脉高压。然而,他患有严重的动脉低血压和无尿,儿茶酚胺治疗(多巴酚丁胺、肾上腺素和去甲肾上腺素)难治性。36小时后,开始抗利尿素治疗,导致动脉血压几乎立即稳定,随后出现利尿。抗利尿激素治疗需要持续三周,以维持足够的动脉血压水平和利尿。脓毒症和肾上腺功能不全被排除为炎症标志物,微生物试验和皮质醇水平正常。在两周大的时候,我们的病人出现电解质紊乱,用氢化可的松成功地治疗了。他不需要肾脏替代治疗。遗传分析发现了一种新的RTD复合杂合突变。目前患者17个月大,经氟可的松和碳酸氢钠治疗,临床情况稳定。他患有二期慢性肾病;血压、运动和认知发育正常。结论:RTD是一种罕见的羊水序列过少的病因。除肺发育不全外,严重的动脉低血压是导致生存率低的原因。我们报告了唯一的第二个存活的RTD婴儿,他在新生儿期不需要肾脏替代治疗。可以推测抗利尿激素的使用是否会阻碍肾替代治疗,因为抗利尿激素通过改善肾血流量而增加尿量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信